Advanced search
Start date
Betweenand


An experimental target-based platform in yeast for screening Plasmodium vivax deoxyhypusine synthase inhibitors

Full text
Author(s):
Show less -
Silva, Suelen Fernandes ; Klippel, Angelica Hollunder ; Sigurdardottir, Sunniva ; Mahdizadeh, Sayyed Jalil ; Tiukova, Ievgeniia ; Bourgard, Catarina ; Salazar-Alvarez, Luis Carlos ; Prado, Heloisa Monteiro do Amaral ; de Araujo, Renan Vinicius ; Costa, Fabio Trindade Maranhao ; Bilsland, Elizabeth ; King, Ross D. ; Massirer, Katlin Brauer ; Eriksson, Leif A. ; Bengtson, Mario Henrique ; Zanelli, Cleslei Fernando ; Sunnerhagen, Per
Total Authors: 17
Document type: Journal article
Source: PLoS Neglected Tropical Diseases; v. 18, n. 12, p. 25-pg., 2024-12-01.
Abstract

The enzyme deoxyhypusine synthase (DHS) catalyzes the first step in the post-translational modification of the eukaryotic translation factor 5A (eIF5A). This is the only protein known to contain the amino acid hypusine, which results from this modification. Both eIF5A and DHS are essential for cell viability in eukaryotes, and inhibiting DHS is a promising strategy to develop new therapeutic alternatives. DHS proteins from many are sufficiently different from their human orthologs for selective targeting against infectious diseases; however, no DHS inhibitor selective for parasite orthologs has previously been reported. Here, we established a yeast surrogate genetics platform to identify inhibitors of DHS from Plasmodium vivax, one of the major causative agents of malaria. We constructed genetically modified Saccharomyces cerevisiae strains expressing DHS genes from Homo sapiens (HsDHS) or P. vivax (PvDHS) in place of the endogenous DHS gene from S. cerevisiae. Compared with a HsDHS complemented strain with a different genetic background that we previously generated, this new strain background was similar to 60-fold more sensitive to an inhibitor of human DHS. Initially, a virtual screen using the ChEMBL-NTD database was performed. Candidate ligands were tested in growth assays using the newly generated yeast strains expressing heterologous DHS genes. Among these, two showed promise by preferentially reducing the growth of the PvDHS-expressing strain. Further, in a robotized assay, we screened 400 compounds from the Pathogen Box library using the same S. cerevisiae strains, and one compound preferentially reduced the growth of the PvDHS-expressing yeast strain. Western blot revealed that these compounds significantly reduced eIF5A hypusination in yeast. The compounds showed antiplasmodial activity in the asexual erythrocyte stage; EC50 in high nM to low mu M range, and low cytotoxicity. Our study demonstrates that this yeast-based platform is suitable for identifying and verifying candidate small molecule DHS inhibitors, selective for the parasite over the human ortholog. (AU)

FAPESP's process: 14/50897-0 - INCT 2014: Open-acess Medicinal Chemistry Centre (OpenMedChem)
Grantee:Katlin Brauer Massirer
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 23/07805-6 - Identification of predictive metabolic signatures for recurrent infections by hypnozoites in patients with vivax malaria (HIPNOPRINT)
Grantee:Luis Carlos Salazar Alvarez
Support Opportunities: Scholarships in Brazil - Technical Training Program - Technical Training
FAPESP's process: 19/24812-0 - Search for inhibitors of the enzyme deoxyhypusine synthase of eukaryotic organisms that cause neglected tropical diseases by high-throughput in vitro drug screening
Grantee:Angélica Hollunder Klippel
Support Opportunities: Scholarships abroad - Research Internship - Doctorate
FAPESP's process: 23/16654-1 - Hit confirmation and optimization of RNA Binding proteins with KH domain.
Grantee:Renan Vinicius de Araujo
Support Opportunities: Scholarships abroad - Research Internship - Doctorate (Direct)
FAPESP's process: 22/10512-8 - Fragment-based hit discovery and characterization of RNA Binding proteins with KH domain
Grantee:Renan Vinicius de Araujo
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 18/16672-1 - Structural determination and search for inhibitors of the enzyme deoxy-hypusine synthase of eukaryotic organisms that cause neglected tropical diseases
Grantee:Angélica Hollunder Klippel
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 15/03553-6 - Engineering yeast cells for drug discovery
Grantee:Elizabeth Bilsland
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 18/07007-4 - Identification of new antimalarial treatments through a target-centred "drug repositioning" approach
Grantee:Elizabeth Bilsland
Support Opportunities: Regular Research Grants